![Peter Hovstadius](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Hovstadius
Directeur Technique/Scientifique/R&D chez
LIPUM AB
Profil
Peter Hovstadius currently works at Lipum AB, as Chief Medical Officer from 2024.
Dr. Hovstadius also formerly worked at Merck Sharp & Dohme AB, as Research Director, XNK Therapeutics AB, as Chief Medical Officer, and Novartis Sverige AB, as Chief Scientific Officer.
Dr. Hovstadius received his doctorate degree from the University of Uppsala.
Postes actifs de Peter Hovstadius
| Sociétés | Poste | Début |
|---|---|---|
| LIPUM AB | Directeur Technique/Scientifique/R&D | 19/08/2024 |
Anciens postes connus de Peter Hovstadius
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Directeur Technique/Scientifique/R&D | - |
Merck Sharp & Dohme AB | Directeur Technique/Scientifique/R&D | - |
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Peter Hovstadius
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Health Technology |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Health Technology |
Lipum AB
 Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
Merck Sharp & Dohme AB |
